S. Gendarme

Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?

M. Antoine, J. Cadranel, K. Kerrou, 2020, Lung cancer.

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

F. Guisier, O. Bylicki, C. Chouaid, 2022, Current oncology.

Risk factors for early mortality of lung cancer patients in France: A nationwide analysis

C. Jung, J. Assié, C. Chouaïd, 2022, Cancer medicine.

Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects

F. Delva, B. Clin, J. Pairon, 2022, Cancers.

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.

F. Guisier, R. Corre, E. Paillaud, 2023, Journal of geriatric oncology.

Monitoring Subsolid Pulmonary Nodules in High-Risk Patients Is Even More Cost-Effective When Combined With a Stop-Smoking Program.

C. Chouaid, S. Gendarme, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis

T. Landre, J. Assié, C. Taleb, 2021, Cancers.

Factors associated with early lung cancer mortality: a systematic review

O. Bylicki, J. Assié, C. Chouaïd, 2021, Expert review of anticancer therapy.

Artificial intelligence to finally enable precision medicine for the management of resected non-small cell lung cancer.

J. Auliac, C. Chouaïd, S. Gendarme, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.